AIMS/HYPOTHESIS: Dyslipidaemia is a main component of the insulin resistance syndrome. The inbred Goto-Kakizaki (GK) rat is a model of spontaneous type 2 diabetes and insulin resistance, which has been used to identify diabetes-related susceptibility loci in genetic crosses. The objective of our study was to test the genetic control of lipid metabolism in the GK rat and investigate a possible relationship with known genetic loci regulating glucose homeostasis in this strain. MATERIALS AND METHODS: Plasma concentration of triglycerides, phospholipids, total cholesterol, HDL, LDL and VLDL cholesterol were determined in a cohort of 151 hybrids of an F2 cross derived from GK and non-diabetic Brown Norway (BN) rats. Data from the genome-wide scan of the F2 hybrids were used to test for evidence of genetic linkage to the lipid quantitative traits. RESULTS: We identified statistically significant quantitative trait loci (QTLs) that control the level of plasma phospholipids and triglycerides (chromosome 1), LDL cholesterol (chromosome 3) and total and HDL cholesterol (chromosomes 1 and 5). These QTLs do not coincide with previously identified diabetes susceptibility loci in a similar cross. The significance of lipid QTLs mapped to chromosomes 1 and 5 is strongly influenced by sex. CONCLUSION/ INTERPRETATION: We established that several genetic loci control the quantitative variations of plasma lipid variables in a GKxBN cross. They appear to be distinct from known GK diabetes QTLs, indicating that lipid metabolism and traits directly relevant to glucose and insulin regulation are controlled by different gene variants in this strain combination.
AIMS/HYPOTHESIS: Dyslipidaemia is a main component of the insulin resistance syndrome. The inbred Goto-Kakizaki (GK) rat is a model of spontaneous type 2 diabetes and insulin resistance, which has been used to identify diabetes-related susceptibility loci in genetic crosses. The objective of our study was to test the genetic control of lipid metabolism in the GK rat and investigate a possible relationship with known genetic loci regulating glucose homeostasis in this strain. MATERIALS AND METHODS: Plasma concentration of triglycerides, phospholipids, total cholesterol, HDL, LDL and VLDL cholesterol were determined in a cohort of 151 hybrids of an F2 cross derived from GK and non-diabetic Brown Norway (BN) rats. Data from the genome-wide scan of the F2 hybrids were used to test for evidence of genetic linkage to the lipid quantitative traits. RESULTS: We identified statistically significant quantitative trait loci (QTLs) that control the level of plasma phospholipids and triglycerides (chromosome 1), LDL cholesterol (chromosome 3) and total and HDL cholesterol (chromosomes 1 and 5). These QTLs do not coincide with previously identified diabetes susceptibility loci in a similar cross. The significance of lipid QTLs mapped to chromosomes 1 and 5 is strongly influenced by sex. CONCLUSION/ INTERPRETATION: We established that several genetic loci control the quantitative variations of plasma lipid variables in a GKxBN cross. They appear to be distinct from known GK diabetes QTLs, indicating that lipid metabolism and traits directly relevant to glucose and insulin regulation are controlled by different gene variants in this strain combination.
Authors: M T Bihoreau; D Gauguier; N Kato; G Hyne; K Lindpaintner; J P Rapp; M R James; G M Lathrop Journal: Genome Res Date: 1997-05 Impact factor: 9.043
Authors: J Galli; L S Li; A Glaser; C G Ostenson; H Jiao; H Fakhrai-Rad; H J Jacob; E S Lander; H Luthman Journal: Nat Genet Date: 1996-01 Impact factor: 38.330
Authors: E S Lander; P Green; J Abrahamson; A Barlow; M J Daly; S E Lincoln; L A Newberg; L Newburg Journal: Genomics Date: 1987-10 Impact factor: 5.736
Authors: R H Wallis; K J Wallace; S C Collins; M McAteer; K Argoud; M T Bihoreau; P J Kaisaki; D Gauguier Journal: Diabetologia Date: 2004-05-26 Impact factor: 10.122
Authors: M-H Giroix; J-C Irminger; G Lacraz; C Noll; S Calderari; J A Ehses; J Coulaud; M Cornut; N Kassis; F Schmidlin; J-L Paul; M Kergoat; N Janel; P A Halban; F Homo-Delarche Journal: Diabetologia Date: 2011-07-10 Impact factor: 10.122
Authors: B M Herrera; H E Lockstone; J M Taylor; M Ria; A Barrett; S Collins; P Kaisaki; K Argoud; C Fernandez; M E Travers; J P Grew; J C Randall; A L Gloyn; D Gauguier; M I McCarthy; C M Lindgren Journal: Diabetologia Date: 2010-03-03 Impact factor: 10.122
Authors: Marc-Emmanuel Dumas; Céline Domange; Sophie Calderari; Andrea Rodríguez Martínez; Rafael Ayala; Steven P Wilder; Nicolas Suárez-Zamorano; Stephan C Collins; Robert H Wallis; Quan Gu; Yulan Wang; Christophe Hue; Georg W Otto; Karène Argoud; Vincent Navratil; Steve C Mitchell; John C Lindon; Elaine Holmes; Jean-Baptiste Cazier; Jeremy K Nicholson; Dominique Gauguier Journal: Genome Med Date: 2016-09-30 Impact factor: 11.117
Authors: Pamela J Kaisaki; Georg W Otto; Karène Argoud; Stephan C Collins; Robert H Wallis; Steven P Wilder; Anthony C Y Yau; Christophe Hue; Sophie Calderari; Marie-Thérèse Bihoreau; Jean-Baptiste Cazier; Richard Mott; Dominique Gauguier Journal: G3 (Bethesda) Date: 2016-11-08 Impact factor: 3.154
Authors: Robert H Wallis; Stephan C Collins; Pamela J Kaisaki; Karène Argoud; Steven P Wilder; Karin J Wallace; Massimiliano Ria; Alain Ktorza; Patrik Rorsman; Marie-Thérèse Bihoreau; Dominique Gauguier Journal: PLoS One Date: 2008-08-13 Impact factor: 3.240
Authors: Pamela J Kaisaki; Georg W Otto; Joanna F McGouran; Amine Toubal; Karène Argoud; Helen Waller-Evans; Clare Finlay; Sophie Caldérari; Marie-Thérèse Bihoreau; Benedikt M Kessler; Dominique Gauguier; Richard Mott Journal: PLoS One Date: 2014-04-17 Impact factor: 3.240